本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国血液技术

72.55
-0.9000-1.23%
盘后72.550.00000.00%17:23 EDT
成交量:73.80万
成交额:5,356.27万
市值:34.85亿
市盈率:21.92
高:74.16
开:74.03
低:72.06
收:73.45
数据加载中...
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/01

重要事件披露

Form 8-K - Current report
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/02/08

重要事件披露

Form 8-K - Current report
2023/12/12

重要事件披露

Form 8-K - Current report
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/12

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/10/10

重要事件披露

Form 8-K - Current report
2023/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans